In this study, we systematically delineated the transcriptional regulatory landscape of THY1 in gastric cancer by identifying six robust putative regulators—PRRX1, TWIST1, SNAI2, MEIS3, VENTX, and EGR2—through an integrative multicohort approach. Here, MEIS3 is linked to gastric cancer.